BioLight announces start of clinical study with DiagnosTear dry eye syndrome diagnostic... - 0 views
-
Alex Parker on 11 Feb 14BioLight Life Sciences Investments announced that DiagnosTear has received all necessary approvals from Sheba Medical Center near Tel Aviv to begin a clinical study with its TeaRx, point-of-care Dry Eye Syndrome diagnostic assay.